Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.

from NYT > Science https://ift.tt/2K2PlFf